StockData

Jyong Biotech Ltd. (MENS) stock

MENSNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 0/30
$1.86+0.06 (+3.33%)

Close on Nov 18, 2026Market cap $141.41MP/E –Yield –

Jyong Biotech operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$3.04M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.04M–
FY2024Dec 31, 2024-$3.62M–
FY2023Dec 31, 2023-$2.60M–

More Jyong Biotech figures

See a number that looks wrong?